Two cases of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis

DOI
  • Terayachi Tai
    Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital Department of Emergency and Critical Care Medicine, Nippon Medical School
  • Igarashi Yutaka
    Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital Department of Emergency and Critical Care Medicine, Nippon Medical School
  • Namatame Kaoru
    Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital Department of Emergency and Critical Care Medicine, Nippon Medical School
  • Hirano Touko
    Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital Department of Emergency and Critical Care Medicine, Nippon Medical School
  • Mizobuchi Taiki
    Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital Department of Emergency and Critical Care Medicine, Nippon Medical School
  • Nakae Ryuta
    Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital Department of Emergency and Critical Care Medicine, Nippon Medical School
  • Yokobori Shoji
    Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital Department of Emergency and Critical Care Medicine, Nippon Medical School

Bibliographic Information

Other Title
  • 抗MDA5抗体陽性皮膚筋炎に伴う急速進行性間質性肺炎を合併した2例

Search this article

Abstract

<p>Anti-MDA5 antibody-positive dermatomyositis is rapidly progressive interstitial pneumonia, which is a rare disease and poor prognosis. It should be diagnosed and treated immediately. In addition, it should be listed as a differential diagnosis in cases of severe respiratory failure because of the similarity in imaging findings with COVID-19. We present two cases of Anti-MDA5 antibody-positive dermatomyositis.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top